- Bestsellers
- Alcoholism
- COVID-19
- Allergy
- Anti Fungal
- Alzheimers
- Anti-Inflammatory
- Anti Viral
- Anti-Depressants
- Antibacterial
- Antibiotics
- Antiparasitic
- Arthritis
- Asthma
- Birth Control
- Blood Pressure
- Cancer
- Cardiovascular
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Drop
- Gastro Health
- General Health
- Hair Loss
- Hepatitis C Virus (HCV)
- HIV
- Hormones
- Men's ED Packs
- Men's Health
- Mental Illness
- Motion Sickness
- Muscle Relaxant
- Pain Relief
- Parkinson’s Disease
- Quit Smoking
- Veterinary Medicines
- Vitamins
- Skin Care
- Sleeping Aids
- Weight Loss
- Women's Health
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Next orders 10% discount
+ Package delivery insurance
+ Next orders 10% discount
Buy cheap Generic Aciphex (Rabeprazole) without dr prescription at Canadian Pharmacy
Aciphex (Rabeprazole 10 mg, 20 mg): Comprehensive Patient Information for Canada
Basic Product Information
| Generic Name (INN) | Rabeprazole (as rabeprazole sodium) |
| Canadian Brand Names / Trade Names | Aciphex (US brand name); in Canada, rabeprazole is marketed primarily as Pariet (AbbVie) and Apo-Rabeprazole, DOM-Rabeprazole EC, Jamp-Rabeprazole, Mylan-Rabeprazole, PMS-Rabeprazole EC, PRO-Rabeprazole, RAN-Rabeprazole, Riva-Rabeprazole EC, Sandoz-Rabeprazole, Sivem Rabeprazole, Teva-Rabeprazole EC, and Pat-Rabeprazole. Aciphex Sprinkle (capsules for oral suspension) is available in the US but not marketed in Canada. |
| ATC Code | A02BC04 |
| Available Dosage Forms and Strengths | Delayed-release (enteric-coated) tablets: 10 mg and 20 mg. Both strengths are available in Canada. |
| Manufacturers | AbbVie (Pariet); Jamp Pharma Corporation (Jamp-Rabeprazole), Sandoz Canada (Sandoz-Rabeprazole), Teva Canada (Teva-Rabeprazole EC), Apotex Inc. (Apo-Rabeprazole), Pharmascience (PMS-Rabeprazole EC), Sanis Health (Sivem Rabeprazole), and others. |
| Prescription Status | Prescription only in Canada. |
Mechanism of Action
In simple terms: Aciphex is a proton pump inhibitor (PPI) that reduces the amount of acid your stomach produces. It works by blocking the tiny pumps in the stomach cells that release acid. By lowering acid levels, it helps heal damage to the food pipe (esophagus) caused by acid reflux, treat stomach and intestinal ulcers, and relieve heartburn. It is also used in combination with antibiotics to treat ulcers caused by H. pylori bacteria.
For specialists: Rabeprazole is a substituted benzimidazole that inhibits gastric acid secretion by specific action on the proton pumps (H+, K+-ATPase enzyme system) of the gastric parietal cells. Unlike omeprazole and esomeprazole, rabeprazole is less dependent on CYP2C19 metabolism for its activation and elimination, which may contribute to more predictable acid suppression across different patient populations. Rabeprazole is rapidly converted to its active form in the acidic environment of the parietal cell canaliculi, where it inhibits the final step of hydrochloric acid production. It has a rapid onset of action, with acid suppression beginning within one hour of oral administration.
Pharmacokinetics
- Absorption: Rabeprazole is rapidly absorbed after oral administration, with peak plasma concentrations reached approximately 2 to 5 hours after dosing. The absolute bioavailability is approximately 52%. Food does not significantly affect the extent of absorption, but it may delay the time to peak concentration.
- Metabolism: Rabeprazole is extensively metabolized in the liver, primarily by non-enzymatic reduction to a thioether derivative, with minor contributions from CYP2C19 and CYP3A4. Because it is less dependent on CYP2C19, rabeprazole has more predictable pharmacokinetics compared with omeprazole and esomeprazole, especially in individuals who are poor CYP2C19 metabolizers.
- Elimination: The elimination half-life is approximately 1 to 2 hours. Rabeprazole is approximately 96% bound to plasma proteins. Approximately 90% of the dose is excreted in urine, primarily as metabolites, and 10% in feces.
- Onset of Action: Acid suppression begins within 1 hour of oral administration. Symptomatic relief of heartburn is typically experienced within the first few days of treatment.
- Duration of Action: The effect on gastric acid secretion persists for approximately 24 hours after a single dose, due to irreversible binding to the proton pump.
Uses in Daily Life and Best Practice Advice
Rabeprazole is prescribed in Canada for the treatment of acid-related conditions. Your physician will determine the appropriate use and dose based on your specific medical situation.
- Typical Uses: Treatment of non-erosive reflux disease (NERD), gastroesophageal reflux disease (GERD) with or without erosive esophagitis, duodenal ulcers, gastric (stomach) ulcers, and pathological hypersecretory conditions such as Zollinger-Ellison syndrome. It is also used in combination with antibiotics for the eradication of Helicobacter pylori in patients with duodenal ulcer.
- Administration: Take the tablet whole with a glass of water. Do not chew, crush, or split the tablet, as this will destroy the enteric coating and reduce effectiveness. For best results, take rabeprazole 30 to 60 minutes before a meal.
- Monitoring: If symptoms do not improve within a reasonable period, or if they worsen, consult your physician. Long-term use should be reassessed periodically, as many long-term PPI prescriptions may not be indicated for continuous use.
- Do Not Stop Without Medical Advice: Do not stop taking this medication without consulting your physician, especially if you have been on long-term therapy. Tapering over 2–4 weeks may be needed to avoid rebound symptoms.
Morning vs. Evening Dosing
Rabeprazole is typically taken once daily. For optimal acid suppression, the recommended time is 30 to 60 minutes before the first meal of the day (usually breakfast). There is no specific clinical recommendation for evening dosing.
- Morning Dosing: The standard recommendation is to take rabeprazole once daily before breakfast.
- Consistency: Take rabeprazole at the same time each day to ensure maximum effectiveness.
- Missed Dose: If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.
- Professional Guidance: Your healthcare provider may adjust the timing based on your condition and other medications.
Administration With or Without Food
Rabeprazole can be taken with or without food, but for optimal acid suppression it should be taken 30 to 60 minutes before a meal. Food does not significantly affect the total amount of medication absorbed, but taking it before a meal ensures that the medication is activated when the proton pumps are most active.
- Take the tablet whole with a full glass of water.
- Do not chew, crush, or split the tablet. Swallow it whole to preserve the enteric coating.
- For best results, take rabeprazole 30 to 60 minutes before a meal.
- Antacids may be used concomitantly with rabeprazole, as no interaction with liquid antacids has been observed.
Interaction Warnings
| Interaction | Advice |
|---|---|
| Atazanavir, Nelfinavir | Rabeprazole may reduce the absorption of these antiretroviral medications. Concomitant use is not recommended. |
| Rilpivirine | PPIs, including rabeprazole, may reduce the absorption of rilpivirine. Concomitant use is not recommended. |
| Ketoconazole, Itraconazole | Rabeprazole may reduce the absorption of these antifungal agents due to increased gastric pH. Monitor clinical response. |
| Warfarin | Studies in healthy subjects have shown that rabeprazole does not have clinically significant interactions with warfarin when given as single oral doses. However, monitor INR during concomitant use. |
| Methotrexate | Rabeprazole may interact with methotrexate when used at the same time. This combination may lead to higher-than-expected amounts of methotrexate in the body and can cause serious side effects. Monitor for methotrexate toxicity. |
| Tacrolimus | Rabeprazole may increase tacrolimus levels. Monitor tacrolimus concentrations and adjust dose as needed. |
| Digoxin | Rabeprazole may increase digoxin levels. Monitor digoxin concentrations and clinical response. |
| Dabigatran | When dabigatran is administered with rabeprazole, the exposure to dabigatran is reduced by about 30%. Monitor for reduced anticoagulant effect. |
| Pimozide | It is recommended to avoid concomitant use of pimozide with rabeprazole. |
| Rifampicin | Rifampicin may reduce the amount of rabeprazole in the blood, potentially reducing its effectiveness. |
Indications for Rabeprazole
| Condition | Status |
|---|---|
| Non-erosive reflux disease (NERD) | Approved (Health Canada) |
| Gastroesophageal reflux disease (GERD) with erosive or ulcerative esophagitis | Approved (Health Canada) |
| Maintenance of healed GERD | Approved (Health Canada) |
| Duodenal ulcer | Approved (Health Canada) |
| Gastric (stomach) ulcer | Approved (Health Canada) |
| Helicobacter pylori eradication (in combination with antibiotics) | Approved (Health Canada) |
| Zollinger-Ellison syndrome and other hypersecretory conditions | Approved (Health Canada) |
"Off-label" means use outside the official approved indication, usually based on current medical guidelines and scientific evidence.
Dosing According to Clinical Indication
| Indication | Adults | Children | Duration |
|---|---|---|---|
| Non-erosive reflux disease (NERD) | 10 mg to 20 mg once daily | Not established | Up to 4 weeks |
| GERD with erosive esophagitis (treatment) | 20 mg once daily | Not established | 4 to 8 weeks; may repeat for an additional 8 weeks if inadequate response |
| Maintenance of healed GERD | 10 mg to 20 mg once daily | Not established | Long-term |
| Duodenal ulcer | 20 mg once daily | Not established | Up to 4 weeks |
| Gastric ulcer | 20 mg once daily | Not established | Up to 6 weeks |
| H. pylori eradication | 20 mg twice daily with amoxicillin 1000 mg and clarithromycin 500 mg twice daily | Not established | 7 days |
| Zollinger-Ellison syndrome | 60 mg once daily initially; dose adjusted based on response | Not established | As directed by physician |
Doses should always be adjusted according to the advice of your physician and depending on your health condition. In Canada, all proton pump inhibitors, including rabeprazole, have a maximum quantity limit of 400 tablets/capsules per 180-day period. Patients taking two rabeprazole 10 mg tablets a day can be switched to one rabeprazole 20 mg tablet a day to avoid reaching the quantity limit.
Side Effects and Safety Profile
| Common (>1%) | Occasional (0.1–1%) | Rare / Serious (<0.1%) | Warnings |
|---|---|---|---|
|
|
|
|
Guidelines for Correct Use
- Take rabeprazole exactly as prescribed by your physician. Do not change your dose without medical advice.
- Take the tablet whole with a full glass of water. Do not chew, crush, or split the tablet.
- For best results, take rabeprazole 30 to 60 minutes before a meal.
- Do not take more than one dose per day unless directed by your physician.
- Use the lowest dose and shortest duration appropriate to your condition.
- Do not stop taking this medication without consulting your physician, especially if you have been on long-term therapy.
- If you are pregnant, planning to become pregnant, or breastfeeding, consult your physician before use.
- If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double the dose.
- Keep all medical appointments for monitoring of your condition.
- Store at room temperature in a dry place. Keep out of reach of children.
Alternative Treatment Options
- Pantoprazole (Pantoloc): A commonly used PPI available in 20 mg and 40 mg tablets. Taken once daily. Preferred during breastfeeding and for patients taking clopidogrel due to fewer interactions.
- Omeprazole (Losec): A widely used PPI available in 10 mg, 20 mg, and 40 mg delayed-release capsules. Taken once daily. Available in generic form in Canada. Preferred during breastfeeding.
- Esomeprazole (Nexium): The S-enantiomer of omeprazole. Available in 20 mg and 40 mg capsules. Taken once daily. Available in generic form in Canada.
- Lansoprazole (Prevacid): A PPI available in 15 mg and 30 mg delayed-release capsules. Taken once daily. Available in generic form in Canada.
- Dexlansoprazole (Dexilant): A dual delayed-release PPI available in 30 mg and 60 mg capsules. Taken once daily.
Comparison: Rabeprazole is distinguished from other PPIs by its more predictable pharmacokinetic profile and its rapid onset of action. It is less dependent on CYP2C19 metabolism, which may be advantageous in patients who are poor metabolizers of CYP2C19. Rabeprazole is considered therapeutically equivalent to other standard-dose PPIs. However, rabeprazole is generally more expensive than omeprazole, pantoprazole, and lansoprazole in Canada. Your physician will determine the best option for your specific condition.
Legal Status, Registration, and Coverage in Canada
- Registration: Rabeprazole is authorized for sale in Canada by Health Canada as a prescription drug. Numerous generic formulations are available in 10 mg and 20 mg delayed-release tablets from manufacturers including Jamp Pharma, Sandoz Canada, Teva Canada, Apotex, Pharmascience, and others. The brand-name Pariet is marketed by AbbVie.
- Prescription Status: Prescription only in Canada.
- Coverage: Coverage varies by province and territory. In Quebec, rabeprazole is covered under the RAMQ formulary. In Ontario, rabeprazole is listed as a Limited Use benefit under the Ontario Drug Benefit (ODB) formulary. In New Brunswick, rabeprazole 10 mg and 20 mg tablets are covered under the provincial drug plan. In British Columbia, rabeprazole is included as a Limited Use benefit under the Modernized Reference Drug Program. All PPIs, including rabeprazole, have a maximum quantity limit of 400 tablets/capsules per 180-day period in Canada.
- Pharmacovigilance: Adverse reactions should be reported to Health Canada's MedEffect Canada program.
Recent Research and Clinical Guidelines (2022–2026)
- The 2025 American Gastroenterological Association guidelines recommend rabeprazole 20 mg daily as first-line treatment for GERD and acute gastritis, with the addition of prokinetics like itopride reserved for specific situations with documented motility disturbances or delayed gastric emptying.
- A 2025 clinical algorithm recommends starting with rabeprazole 20 mg daily alone for 4–8 weeks, taken 30–60 minutes before meals for optimal acid suppression, and considering increasing to twice-daily dosing before adding other medications.
- The American Gastroenterological Association recommends esomeprazole 20–40 mg twice daily or rabeprazole 20–40 mg twice daily as the preferred PPIs for H. pylori eradication due to their superior potency compared with other PPIs.
- Current guidelines recommend that patients without definitive ongoing indications for PPI therapy should be considered for de-prescribing trials after symptom control is achieved.
- NICE guidelines (2025) recommend rabeprazole 20 mg once daily as a standard-dose PPI for dyspepsia, esophagitis, and peptic ulcer disease.
Availability and Supply in Canada
| Packaging Format | Typical Price (CAD, per month) | Availability |
|---|---|---|
| Rabeprazole 10 mg tablet (generic) | Approximately $12–$30 per month | Available at pharmacies across Canada; prescription required |
| Rabeprazole 20 mg tablet (generic) | Approximately $12–$30 per month | Available at pharmacies; multiple generic manufacturers |
| Pariet 10 mg tablet (brand) | Brand price varies; generally higher than generic | May be available; generic alternatives are more commonly dispensed |
| Pariet 20 mg tablet (brand) | Brand price varies; generally higher than generic | May be available; generic alternatives are more commonly dispensed |
Prices and availability may vary by province, territory, and pharmacy. Generic rabeprazole formulations are widely available in Canada and are generally more affordable than the brand-name Pariet. A product recall was issued for JAMP-Rabeprazole 20 mg (DIN 02415291, lot EG23RJC005) in April 2024 because the affected lot may contain JAMP-Rabeprazole 10 mg tablets. Check with your local pharmacy for current pricing and availability.
Frequently Asked Questions (FAQ)
- What is the difference between Aciphex 10 mg and 20 mg?
The 20 mg dose is typically used for acute treatment of GERD with erosive esophagitis, duodenal ulcers, and gastric ulcers. The 10 mg dose is often used for maintenance therapy, non-erosive reflux disease (NERD), and for patients who need a lower dose. Your physician will determine the appropriate dose for your condition. - How long does rabeprazole take to work?
Rabeprazole begins reducing stomach acid within 1 hour of the first dose. Symptomatic relief of heartburn is typically experienced within the first few days of treatment, but it may take up to 4 weeks for full effect in some conditions. - Can I take rabeprazole with food?
Yes, but for best results, it should be taken 30 to 60 minutes before a meal. Food does not significantly affect the total amount of medication absorbed, but taking it before a meal ensures that the medication is activated when the proton pumps are most active. - What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time. - Can I stop taking rabeprazole if I feel better?
Do not stop taking rabeprazole without consulting your physician. Abrupt discontinuation may cause your symptoms to return, especially after long-term use. Your physician will advise you on whether a gradual dose reduction (tapering over 2–4 weeks) is needed. - What are the long-term risks of taking rabeprazole?
Long-term use of PPIs, including rabeprazole, has been associated with an increased risk of bone fractures, low magnesium levels, vitamin B12 deficiency, and certain infections. Use the lowest dose and shortest duration appropriate to your condition. Discuss any concerns with your physician. - Is rabeprazole safe during pregnancy?
Rabeprazole should be used during pregnancy only if clearly needed. There are no adequate and well-controlled studies of rabeprazole in pregnant women. Consult your physician if you are pregnant, planning to become pregnant, or breastfeeding. - Is rabeprazole safe during breastfeeding?
It is not known whether rabeprazole is excreted in human breast milk. Consult your physician before use if breastfeeding. Omeprazole and pantoprazole are preferred PPIs during breastfeeding. - Are there generic versions of rabeprazole available in Canada?
Yes. Generic rabeprazole is widely available in Canada in both 10 mg and 20 mg strengths from multiple manufacturers, including Jamp Pharma, Sandoz Canada, Teva Canada, Apotex, and Pharmascience. Generic versions are generally more affordable than the brand-name Pariet. - What is the difference between Aciphex and Pariet?
Aciphex is the brand name for rabeprazole in the United States. In Canada, the brand name for rabeprazole is Pariet. Both contain the same active ingredient, rabeprazole sodium. Generic rabeprazole products are also available in Canada.
How to buy Generic Aciphex without rx in Canada.
| Shipping method | Delivery time | Price | |
Delivery |
14-21 days | 14.95$ | Tracking# available in 4 days |
Delivery |
9-14 days | 30$ | Tracking# available in 2 days |
- Shipping worldwide
- Confidentiality and anonymity guarantee
- Safe and secure
- Discrete looking packages
- Dispatch orders within 24 hours
- 100% success delivery

